VALENCIA, Calif., June 16 /PRNewswire-FirstCall/ -- MannKind
Corporation (Nasdaq: MNKD), focused on discovering, developing and
commercializing treatments for diabetes and cancer, announced today that it
will present at upcoming conferences.
-- 18th Annual Wachovia Nantucket Equity Conference on Monday, June 23,
2008 at 11:45 AM (Eastern Time) at The White Elephant in Nantucket
-- 2nd Annual Jefferies Healthcare Conference on Thursday, June 26, 2008
at 2:00 PM (Eastern Time) in New York
Interested parties can access a link to the live web cast of the presentations in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of each presentation will be available for 14 days.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.
|SOURCE MannKind Corporation|
Copyright©2008 PR Newswire.
All rights reserved